(secondQuint)Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part II) (DCLI-II).

 The trial includes two parts and here is part II.

 This part is a multi-center, prospective, registration study which focuses on the treatment of below-knee arterial lesion.

 Totally 130 patients will be entered into this part.

 They should suffer ischemic symptom with Rutherford 3-6 for the occlusion of the below-knee arteries(anterior tibial,posterior tibial or peroneal artery).

 According to the lesion length, the patients will accept transluminal angioplasty or below-knee arterial bypass.

 They will be followed up for 3 years.

 Study examinations will be done at screening, procedure time, 1, 6, 12, 24 and 36 months after procedure.

.

 Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part II) (DCLI-II)@highlight

The purpose of this trial is to find out the appropriate way to treat DM patients with critical limb ischemia.

 This trial includes two parts.

 Part I focuses on the treatment of femoral arterial lesion and part II focuses on the treatment of below-knee arterial lesion.

